Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| 1 |
Lowe's Companies
LOW
|
+$520M |
| 2 |
Industrial Select Sector SPDR Fund
XLI
|
+$329M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$328M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$283M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$269M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$2.08B |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$253M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$232M |
| 4 |
SPDR S&P Global Natural Resources ETF
GNR
|
+$216M |
| 5 |
VanEck Oil Services ETF
OIH
|
+$192M |
Sector Composition
| 1 | Technology | 17.62% |
| 2 | Healthcare | 10.9% |
| 3 | Financials | 9.91% |
| 4 | Consumer Discretionary | 9.06% |
| 5 | Industrials | 5.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1726
LGI Homes
LGIH
$1.3B
| $1.59M | ﹤0.01% |
19,493
-1,061
| -5% | -$86.4K |
|
1727
Arcellx
ACLX
$4.32B
| $1.58M | ﹤0.01% |
84,262
-31,629
| -27% | -$594K |
|
1728
Bank OZK
OZK
$5.92B
| $1.58M | ﹤0.01% |
39,954
-2,002
| -5% | -$79.2K |
|
1729
Vanda Pharmaceuticals
VNDA
$265M
| $1.58M | ﹤0.01% |
159,919
+42,440
| +36% | +$419K |
|
1730
FIVE9
FIVN
$2.05B
| $1.58M | ﹤0.01% |
21,045
-100,769
| -83% | -$7.56M |
|
1731
RAPT Therapeutics
RAPT
$328M
| $1.58M | ﹤0.01% |
8,194
+3,860
| +89% | +$743K |
|
1732
Interactive Brokers
IBKR
$29B
| $1.57M | ﹤0.01% |
98,552
+9,980
| +11% | +$159K |
|
1733
IDEAYA Biosciences
IDYA
$2.26B
| $1.57M | ﹤0.01% |
105,510
-97,988
| -48% | -$1.46M |
|
1734
H.B. Fuller
FUL
$3.28B
| $1.57M | ﹤0.01% |
26,157
-49,550
| -65% | -$2.98M |
|
1735
Community Bank
CBU
$3.2B
| $1.57M | ﹤0.01% |
26,176
+1,338
| +5% | +$80.4K |
|
1736
Nurix Therapeutics
NRIX
$645M
| $1.57M | ﹤0.01% |
120,518
+45,253
| +60% | +$590K |
|
1737
BlackLine
BL
$3.28B
| $1.57M | ﹤0.01% |
26,151
-28,400
| -52% | -$1.7M |
|
1738
Sonoco
SON
$4.57B
| $1.56M | ﹤0.01% |
27,479
+17,885
| +186% | +$1.02M |
|
|
LX
1739
LexinFintech Holdings
LX
$971M
| $1.56M | ﹤0.01% |
921,633
| – | – |
|
1740
COPT Defense Properties
CDP
$3.43B
| $1.55M | ﹤0.01% |
66,775
+2,343
| +4% | +$54.4K |
|
1741
Pacira BioSciences
PCRX
$1.2B
| $1.55M | ﹤0.01% |
29,120
+639
| +2% | +$34K |
|
|
MDC
1742
DELISTED
M.D.C. Holdings, Inc.
MDC
| $1.55M | ﹤0.01% |
56,360
-2,518
| -4% | -$69.1K |
|
|
ABB
1743
DELISTED
ABB Ltd
ABB
| $1.55M | ﹤0.01% |
60,172
-697
| -1% | -$17.9K |
|
1744
MGIC Investment
MTG
$6.53B
| $1.54M | ﹤0.01% |
120,306
-3,607
| -3% | -$46.3K |
|
|
EGRX
1745
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $1.54M | ﹤0.01% |
58,391
+31,113
| +114% | +$822K |
|
|
OPA
1746
DELISTED
Magnum Opus Acquisition Limited
OPA
| $1.54M | ﹤0.01% |
155,434
| – | – |
|
1747
HUB Group
HUBG
$2.18B
| $1.54M | ﹤0.01% |
44,688
+6,934
| +18% | +$239K |
|
|
AMED
1748
DELISTED
Amedisys
AMED
| $1.54M | ﹤0.01% |
15,895
+4,983
| +46% | +$483K |
|
1749
Certara
CERT
$1.84B
| $1.54M | ﹤0.01% |
115,777
+85,654
| +284% | +$1.14M |
|
1750
StoneCo
STNE
$5.19B
| $1.54M | ﹤0.01% |
161,073
-53,638
| -25% | -$511K |
|